The report "Pharmaceutical Packaging Equipment Market by Product (Primary: Aseptic Filling and Sealing Equipment), Formulation (Liquid Packaging Equipment: Aseptic Liquid), Automation (Manual), End User (Pharma Manufacturing Companies)—Global Forecast to 2030", is projected to reach USD 14.3 billion by 2030 from USD 10.5 billion in 2025, at a CAGR of 6.3% during the forecast period.
Browse 437 market data Tables and 67 Figures spread through 442 Pages and in-depth TOC on "Pharmaceutical Packaging Equipment Market - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-packaging-equipment-market-19845828.html
The pharmaceutical packaging equipment market is driven by the increasing global demand for safe, compliant, and traceable drug packaging, fueled by stringent regulations such as the DSCSA and FMD. The growth in biologics, injectables, and personalized medicines is spurring demand for advanced, aseptic, and flexible packaging solutions. Technological innovations, including AI-driven automation, robotics, and real-time quality control, are improving efficiency and reducing human error. However, high equipment costs, long validation timelines, and complex compliance requirements pose major restraints. Small- and mid-sized manufacturers encounter barriers due to limited budgets and technical expertise, which slows the adoption of modern systems in cost-sensitive or emerging markets.
The pharmaceutical packaging equipment market is further segmented based on the product, application, end-user, and region.
The primary packaging equipment held the highest product market share in 2024.
Primary packaging equipment plays a crucial role in the pharmaceutical industry, holding the largest market share due to its direct impact on safeguarding the integrity, sterility, and efficacy of various drug formulations. This equipment is essential for an array of dosage forms, including tablets, liquids, and injectables, where maintaining the quality and safety of the product is paramount. One of the key functions of primary packaging is to ensure that pharmaceuticals comply with stringent regulatory standards set by health authorities. This compliance is vital not only for consumer safety but also for the approval processes that allow drugs to enter the market. As the demand for unit-dose formats continues to rise, driven by both patient convenience and the need for accurate dosing, the adoption of advanced primary packaging solutions has surged. Moreover, these advancements are becoming increasingly important in high-throughput packaging environments, where efficiency and speed are critical to meet the growing demands of both generic and branded pharmaceutical production lines. This evolution in packaging technology is helping manufacturers optimize their operations while ensuring that the products maintained within these packages meet the highest standards of quality and effectiveness. Overall, the landscape of primary packaging equipment is shaped by the dual pressures of regulatory compliance and market demand, leading to widespread innovation and adoption across the pharmaceutical sector.
The liquid packaging equipment segment accounted for the largest formulation market share in 2024.
Liquid packaging equipment dominates the market, primarily because of the increasing demand for various liquid pharmaceuticals, including syrups, injectables, eye drops, and vaccines. These products necessitate sophisticated packaging solutions that ensure precise, sterile filling and airtight sealing, which is crucial for maintaining product integrity and safety. The precision required in the packaging process is driving many companies to adopt advanced automated systems that enhance efficiency and accuracy. Additionally, there is a growing regulatory focus on contamination-free packaging within the pharmaceutical sector. Regulatory bodies are emphasizing the importance of non-contaminated packaging processes to safeguard public health, which in turn accelerates the demand for high-speed liquid packaging lines that integrate automation and cutting-edge technology. As a result, pharmaceutical manufacturing facilities are increasingly investing in these automated solutions to comply with strict regulations while ensuring production efficiency and reliability. This trend underscores the vital role that liquid packaging equipment plays in meeting the needs of a rapidly evolving pharmaceutical landscape.
In 2024, Europe commanded the largest regional market share.
Europe dominates the pharmaceutical packaging equipment market, primarily due to its robust pharmaceutical manufacturing infrastructure, stringent regulatory landscape, and proactive integration of advanced automation technologies. Key players are concentrated in countries like Germany, Switzerland, and Italy, which host major pharma equipment manufacturers and significant global drug producers, resulting in a highly efficient supply chain. The stringent compliance requirements set forth by the EU Good Manufacturing Practices (EU-GMP), the Falsified Medicines Directive (FMD), and serialization mandates have driven the need for high-precision packaging systems that meet regulatory standards. Furthermore, the region's increasing investment in research and development, particularly in biologics and contract manufacturing, along with a strong focus on quality assurance and traceability, solidifies Europe's preeminence in the pharmaceutical packaging equipment sector.
The prominent players in the global pharmaceutical packaging equipment market are Syntegon Technology GmbH (Germany), Industria Macchine Automatiche (IMA) S.p.A (Italy), Körber AG (Germany), Coesia S.p. A. (Italy), Marchesini Group S.p.A (Italy), Bausch+Ströbel (Germany), Maschinefabrik Ilshofen GmbH+Co. KG (Germany), Romaco Group (Germany), Uhlmann (Germany), Maquinaria Industries Dara, SL (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/